MichaelFarbaniecMD
Cardiology • Hershey, PAEchocardiography, Non-Invasive Cardiology, Preventive Cardiology, Exercise Physiology and Cardiac Rehabilitation
Assistant Professor of Medicine / Medical Director, Cardiac Rehab / Medical Director, Cardiovascular Disease Prevention / Associate Program Director, Cardiovascular Disease Fellowship / Heart and Vascular Institute Penn State Milton S. Hershey Medical Center
Dr. Farbaniec is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
Hershey, PA 17033Phone+1 717-531-8521
Summary
- Dr. Michael Farbaniec is a cardiologist in Hershey, PA and is affiliated with Penn State Milton S. Hershey Medical Center. He received his medical degree from Pennsylvania State University College of Medicine and has been in practice 10 years. He specializes in echocardiography, cardiothoracic imaging, non-invasive cardiology, and preventive cardiology.
Education & Training
Penn State Milton S Hershey Medical CenterFellowship, Cardiovascular Disease, 2014 - 2017- Penn State Milton S Hershey Medical CenterChief Residency, Internal Medicine, 2013 - 2014
- Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2010 - 2013
Pennsylvania State University College of MedicineClass of 2010
Certifications & Licensure
PA State Medical License 2010 - 2024- American Board of Internal Medicine Cardiovascular Disease
- American Society of EchocardiographyBoard Certified
Clinical Trials
- A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) Start of enrollment: 2021 Jun 25
- Colchicine and Spironolactone in Patients With MI / SYNERGY Stent Registry Start of enrollment: 2018 Feb 01
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a) Start of enrollment: 2021 Jul 28
- Join now to see all
Publications & Presentations
PubMed
- Prevalence of left atrial myopathy in people presenting for ablation of cavotricuspid isthmus-dependent right atrial flutter and the risk of developing atrial fibrilla...Benjamin Walters, Michael Farbaniec, Asma Khurseed, Mario D Gonzalez, Gerald V Naccarelli
Journal of Interventional Cardiac Electrophysiology. 2024-11-01 - 1 citationsLeft Atrial Mechanical Dysfunction Is Associated With Atrial Fibrillation and Recurrent Stroke After Cryptogenic Stroke.Joseph Raco, Ravi Shah, Michael Farbaniec, Faye L Norby, Megan Mann
Journal of Stroke. 2024-05-01 - 1 citationsCardiovascular assessment in cirrhosis: is global longitudinal strain altered in cirrhosis? A meta-analysis and review.Ryan Wilson, Mohammad Ahmed, Matthew Nudy, Michael Farbaniec
Echocardiography. 2023-05-01
Press Mentions
Understanding Your Cholesterol NumbersFebruary 7th, 2023- Cancer Mortality Rates Increased for Older Seniors with T2DMFebruary 3rd, 2023
- Most US Adults Support Banning Sales of All Tobacco Products, CDC Survey SaysFebruary 2nd, 2023
- Join now to see all
Professional Memberships
- Fellow
- National Lipid AssociationMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
